Xu Chang1, Xing Guo1, Xiaole Li2, Xiaowei Han3, Xiaoxiao Li2, Xiaoyan Liu2, Jialiang Ren4. 1. Department of Radiology, Heping Hospital Affiliated to Changzhi Medical College, Changzhi, China. 2. Department of Radiology, Graduate School of Changzhi Medical College, Changzhi, China. 3. Department of Radiology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China. 4. Department of Pharmaceutical Diagnostics, GE Healthcare China, Beijing, China.
Abstract
PURPOSE: This study was designed to evaluate the predictive performance of contrast-enhanced CT-based radiomic features for the personalized, differential diagnosis of esophagogastric junction (EGJ) adenocarcinoma at stages T3 and T4a. METHODS: Two hundred patients with T3 (n = 44) and T4a (n = 156) EGJ adenocarcinoma lesions were enrolled in this study. Traditional computed tomography (CT) features were obtained from contrast-enhanced CT images, and the traditional model was constructed using a multivariate logistic regression analysis. A radiomic model was established based on radiomic features from venous CT images, and the radiomic score (Radscore) of each patient was calculated. A combined nomogram diagnostic model was constructed based on Radscores and traditional features. The diagnostic performances of these three models (traditional model, radiomic model, and nomogram) were assessed with receiver operating characteristics curves. Sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and areas under the curve (AUC) of models were calculated, and the performances of the models were evaluated and compared. Finally, the clinical effectiveness of the three models was evaluated by conducting a decision curve analysis (DCA). RESULTS: An eleven-feature combined radiomic signature and two traditional CT features were constructed as the radiomic and traditional feature models, respectively. The Radscore was significantly different between patients with stage T3 and T4a EGJ adenocarcinoma. The combined nomogram performed the best and has potential clinical usefulness. CONCLUSIONS: The developed combined nomogram might be useful in differentiating T3 and T4a stages of EGJ adenocarcinoma and may facilitate the decision-making process for the treatment of T3 and T4a EGJ adenocarcinoma.
PURPOSE: This study was designed to evaluate the predictive performance of contrast-enhanced CT-based radiomic features for the personalized, differential diagnosis of esophagogastric junction (EGJ) adenocarcinoma at stages T3 and T4a. METHODS: Two hundred patients with T3 (n = 44) and T4a (n = 156) EGJ adenocarcinoma lesions were enrolled in this study. Traditional computed tomography (CT) features were obtained from contrast-enhanced CT images, and the traditional model was constructed using a multivariate logistic regression analysis. A radiomic model was established based on radiomic features from venous CT images, and the radiomic score (Radscore) of each patient was calculated. A combined nomogram diagnostic model was constructed based on Radscores and traditional features. The diagnostic performances of these three models (traditional model, radiomic model, and nomogram) were assessed with receiver operating characteristics curves. Sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and areas under the curve (AUC) of models were calculated, and the performances of the models were evaluated and compared. Finally, the clinical effectiveness of the three models was evaluated by conducting a decision curve analysis (DCA). RESULTS: An eleven-feature combined radiomic signature and two traditional CT features were constructed as the radiomic and traditional feature models, respectively. The Radscore was significantly different between patients with stage T3 and T4a EGJ adenocarcinoma. The combined nomogram performed the best and has potential clinical usefulness. CONCLUSIONS: The developed combined nomogram might be useful in differentiating T3 and T4a stages of EGJ adenocarcinoma and may facilitate the decision-making process for the treatment of T3 and T4a EGJ adenocarcinoma.
Keywords:
American Joint Committee on Cancer; Tumor-Node-Metastasis 8th edition; Union for International Cancer Control classification; esophagogastric junction adenocarcinoma; gastric cancer; radiomics
Authors: G L Zheng; J J Li; G Q Xiang; J Zhu; Y Zhao; H T Zhu; D Yang; Y Wang; J Zhang; X Y Meng; Z C Zheng Journal: Zhonghua Zhong Liu Za Zhi Date: 2018-03-23
Authors: Ahmed Hosny; Chintan Parmar; John Quackenbush; Lawrence H Schwartz; Hugo J W L Aerts Journal: Nat Rev Cancer Date: 2018-08 Impact factor: 60.716
Authors: Meghan G Lubner; Andrew D Smith; Kumar Sandrasegaran; Dushyant V Sahani; Perry J Pickhardt Journal: Radiographics Date: 2017 Sep-Oct Impact factor: 5.333
Authors: Edmund A Mroz; Aaron D Tward; Aaron M Tward; Rebecca J Hammon; Yin Ren; James W Rocco Journal: PLoS Med Date: 2015-02-10 Impact factor: 11.069
Authors: Wenya Linda Bi; Ahmed Hosny; Matthew B Schabath; Maryellen L Giger; Nicolai J Birkbak; Alireza Mehrtash; Tavis Allison; Omar Arnaout; Christopher Abbosh; Ian F Dunn; Raymond H Mak; Rulla M Tamimi; Clare M Tempany; Charles Swanton; Udo Hoffmann; Lawrence H Schwartz; Robert J Gillies; Raymond Y Huang; Hugo J W L Aerts Journal: CA Cancer J Clin Date: 2019-02-05 Impact factor: 508.702
Authors: Li Yang; Junyi Sun; Xianbo Yu; Yang Li; Min Li; Jing Liu; Xiangming Wang; Gaofeng Shi Journal: Front Oncol Date: 2022-03-21 Impact factor: 6.244